Rhythm Pharmaceuticals buy Guggenheim
Start price
21.10.24
/
50%
€46.40
Target price
21.10.25
€64.45
Performance (%)
87.50%
Price
07:33
?
Summary
This prediction is currently active. With a performance of 87.50% the BUY prediction by Guggenheim is a big success. This prediction currently runs until 21.10.25. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rhythm Pharmaceuticals | 2.959% | 2.959% |
| iShares Core DAX® | -0.099% | 0.273% |
| iShares Nasdaq 100 | -1.085% | 1.502% |
| iShares Nikkei 225® | -0.835% | 3.273% |
| iShares S&P 500 | 0.099% | 1.988% |
Comments by Guggenheim for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is now covered by analysts at Guggenheim. They set a "buy" rating and a $70.00 price target on the stock.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Guggenheim for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€77.50
06.08.25
06.08.25
€103.73
06.08.26
06.08.26
12.26%
07:33
07:33
